The clinical test will comprise 6 patients and is led by Jianwu DAI of this institute. The patients will be implanted mesenchymal stem cells and a collagen complex made up of collagen scaffold fibers, together with collagen binding brain-derived neurotrophic factor (BDNF). Previous tests on rats and dogs showed positive results. If successful, 20 – 30 more patients will be treated in the future.

CAS news release, Jan. 19, 2015